Attitudes to outcomes measured in clinical trials of cardiovascular prevention
Author(s) -
Michelle Canavan,
Andrew Smyth,
Suganthy Robinson,
Irene Gibson,
Caroline Costello,
Shaun T. O’Keeffe,
T. N. Walsh,
E. C. Mulkerrin,
Martin O’Donnell
Publication year - 2015
Publication title -
qjm
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.427
H-Index - 118
eISSN - 1460-2725
pISSN - 1460-2393
DOI - 10.1093/qjmed/hcv132
Subject(s) - medicine , dementia , clinical trial , stroke (engine) , randomized controlled trial , gerontology , family medicine , disease , mechanical engineering , engineering
Selecting outcome measures in cardiovascular prevention trials should be informed by their importance to selected populations. Major vascular event outcomes are usually prioritized in these trials with considerably less attention paid to cognitive and functional outcomes.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom